We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.65%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$260B
AUM Growth
+$14.3B
(+5.8%)
Cap. Flow
-$9.91B
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
3,378
New
92
Increased
1,419
Reduced
1,604
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$292M |
| 2 |
Merck
MRK
|
+$239M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$232M |
| 4 |
Intuitive Surgical
ISRG
|
+$225M |
| 5 |
Walmart Inc
WMT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.01B |
| 2 |
Apple
AAPL
|
+$979M |
| 3 |
PPLI
People Inc
PPLI
|
+$793M |
| 4 |
Tesla
TSLA
|
+$671M |
| 5 |
Microsoft
MSFT
|
+$654M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.21% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 11.5% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
John B. Sanfilippo & Son
JBSS
$972M
| $4.75M | ﹤0.01% |
63,018
-360
| -0.6% | -$30K |
|
1927
Universal Corp
UVV
$1.27B
| $4.74M | ﹤0.01% |
113,236
+6,665
| +6% | +$285K |
|
1928
Enerpac Tool Group
EPAC
$1.93B
| $4.73M | ﹤0.01% |
251,601
+212
| +0.1% | +$4.23K |
|
1929
Matthews International
MATW
$739M
| $4.72M | ﹤0.01% |
211,305
+31,084
| +17% | +$667K |
|
1930
Greif
GEF
$5.04B
| $4.72M | ﹤0.01% |
130,441
-2,059
| -2% | -$75.9K |
|
1931
Phibro Animal Health
PAHC
$1.39B
| $4.71M | ﹤0.01% |
270,911
-157,390
| -37% | -$3.36M |
|
1932
Liberty Global Class C
LBTYK
$3.49B
| $4.71M | ﹤0.01% |
229,341
+63,569
| +38% | +$1.4M |
|
|
ESPR
1933
DELISTED
Esperion Therapeutics
ESPR
| $4.7M | ﹤0.01% |
126,359
-38,767
| -23% | -$1.54M |
|
1934
US Physical Therapy
USPH
$1.22B
| $4.69M | ﹤0.01% |
54,029
-2,787
| -5% | -$240K |
|
1935
Pitney Bowes
PBI
$2.39B
| $4.69M | ﹤0.01% |
882,589
+27,274
| +3% | +$126K |
|
1936
Penske Automotive Group
PAG
$14.2B
| $4.67M | ﹤0.01% |
97,927
-12,787
| -12% | -$594K |
|
|
ECOL
1937
DELISTED
US Ecology, Inc.
ECOL
| $4.65M | ﹤0.01% |
142,476
+22,411
| +19% | +$784K |
|
|
TUP
1938
DELISTED
Tupperware Brands Corporation
TUP
| $4.65M | ﹤0.01% |
230,520
-4,821
| -2% | -$73.3K |
|
1939
UroGen Pharma
URGN
$2.29B
| $4.63M | ﹤0.01% |
240,248
-96,901
| -29% | -$2.19M |
|
1940
Horizon Bancorp
HBNC
$1.04B
| $4.63M | ﹤0.01% |
458,885
+31,257
| +7% | +$324K |
|
|
CLCT
1941
DELISTED
Collectors Universe
CLCT
| $4.59M | ﹤0.01% |
92,850
+17,048
| +22% | +$732K |
|
|
AXDX
1942
DELISTED
Accelerate Diagnostics
AXDX
| $4.59M | ﹤0.01% |
43,095
+22,742
| +112% | +$3.16M |
|
1943
iShares International Dividend Growth ETF
IGRO
$1.32B
| $4.59M | ﹤0.01% |
84,000
| – | – |
|
1944
Ubiquiti
UI
$34.3B
| $4.58M | ﹤0.01% |
27,498
-4,496
| -14% | -$793K |
|
|
YMAB
1945
DELISTED
Y-mAbs Therapeutics
YMAB
| $4.58M | ﹤0.01% |
119,269
-32,461
| -21% | -$1.29M |
|
1946
ADT
ADT
$5.58B
| $4.57M | ﹤0.01% |
559,741
+86,644
| +18% | +$843K |
|
|
OIBR.C
1947
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $4.57M | ﹤0.01% |
3,153,691
-297,500
| -9% | -$425K |
|
|
PRA
1948
DELISTED
ProAssurance
PRA
| $4.56M | ﹤0.01% |
291,632
-75,947
| -21% | -$1.13M |
|
|
INFN
1949
DELISTED
Infinera Corporation Common Stock
INFN
| $4.56M | ﹤0.01% |
739,622
+42,246
| +6% | +$296K |
|
|
ADAM
1950
Adamas Trust
ADAM
$883M
| $4.55M | ﹤0.01% |
446,034
-7,132
| -2% | -$74.3K |
|
Similar funds
VFT
Nuveen's Q3 2020 Portfolio in Review
As of Q3 2020, Nuveen held 3,378 positions worth $260B, up 5.8% from $246B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen withdrew a net $9.91B in Q3 2020, closing 90 positions and reducing 1,604 holdings. Its most notable exit was LogMein, Inc., an estimated $32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Nuveen opened a new position in Pactiv Evergreen Inc. Common stock worth $106M.
- Nuveen's largest Q3 2020 buy was Pactiv Evergreen Inc. Common stock: 8,319,656 shares worth $106M.
- Nuveen added most to JD.com in Q3 2020, an estimated $292M increase.
- Nuveen's biggest Q3 2020 reduction was Amazon, cutting an estimated $1.01B.
- Nuveen fully exited LogMein, Inc. in Q3 2020, selling an estimated $32M.
- Nuveen's ten largest holdings make up 23% of its $260B portfolio in Q3 2020.
- Nuveen opened 92 new positions and closed 90 in Q3 2020.
- Nuveen's portfolio value rose 5.8% quarter-over-quarter to $260B.
Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.